We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Amryt Pharma Plc | LSE:AMYT | London | Ordinary Share | GB00BKLTQ412 | ORD 6P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 143.00 | 151.00 | 170.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
31/12/2018 22:20 | mdalos131 Dec '18 - 21:51 - 4032 of 4032 (Filtered) He's wasting his time if he's expecting me to read his posts. mdalos deserves our pity because he's obviously seriously mentally unbalanced. | papillon | |
31/12/2018 21:49 | mdalos131 Dec '18 - 21:43 - 4029 of 4029 (Filtered) | papillon | |
31/12/2018 21:49 | Paphead do you think the more you say it the higher the share price will go? You are a rank amateur who knows nothing about share dealing. You might as well go to casino and talk a good load of rubbish about the number 25 and then put 10 p on it | positivitynicholas | |
31/12/2018 21:31 | mdalos131 Dec '18 - 21:21 - 4027 of 4027 (Filtered) The only poster on advfn who DELETES all of his posts within days of posting. Why go to the trouble of deleting all of your posts? Why does he do it? He's obviously a suitable case for treatment! I can't figure him out. Only a "shrink" could give an answer to my question. I've ignored the bearish AMYT chart for around 18 months. Why? Because I believe that the AP101 Phase III trial for EB will be a resounding success. As the share price has declined I've had small top ups so that now I'm around 12% up on paper. The RNS dated 19/12/2018 further confirms my belief. | papillon | |
31/12/2018 21:10 | mdalos131 Dec '18 - 20:11 - 4025 of 4025 (Filtered) | papillon | |
31/12/2018 16:36 | mdalos131 Dec '18 - 16:14 - 4023 of 4023 (Filtered) | papillon | |
31/12/2018 15:11 | mdalos131 Dec '18 - 15:09 - 4020 of 4020 (Filtered) | papillon | |
31/12/2018 13:49 | I was referring to the 33p | alphabravo321 | |
31/12/2018 13:20 | mdalos1 31 Dec '18 - 12:05 - 4015 of 4016 (Filtered) "Lets hope you are right..." LET'S HOPE NOT, alphabravo321, IF THIS POST BY mdalos, FROM 5/6 WEEKS AGO, IS ANYTHING TO GO BY! LOL. mdalos1 - 23 Nov 2018 - 23:09:43 - 3723 of 3724 Amryt Pharma - AMYT Charts ? Business structure ? Out-pourings ? Indebtedness ? Losses ? Declining share price ? >50% chance of Trial failing 11.75p 8.75p It's Fulham not City !! | papillon | |
31/12/2018 12:48 | Lets hope you are right... | alphabravo321 | |
31/12/2018 11:29 | One final top up to bring me to an even number! | alphabravo321 | |
30/12/2018 23:22 | Stick to a beer or three......! Inveterate gamblers! In my next life I will be really, really, really good! Happy days | bazworth | |
30/12/2018 22:51 | I remember some woman in the Sunday Times picking a lovely little share called Telewest as a sure thing. Lost 99% of its value during the year. Yes reader I invested. | volsung | |
30/12/2018 22:40 | I remember TRK back in the heady days of the dot com boom, bazworth. Michael Walters was always tipping them in the Daily Mail. They were over £5 per share back in those days. TRK was overtaken by events, such as the awareness of climate change, which made their "revolutionary" gearbox a non starter. Newspaper tips are invariably best ignored. I was reading the S.Times today and one of their tips for 2018 was an AIM listed biotech, FARN. It has lost 93% of it's value since the start of 2018. In fact most of the S.Times tips for 2018 have lost investors money. The average is down over 20%, no doubt not helped by that FARN tip, but there were also some other big losers. | papillon |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions